PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.\', \'Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.\', \'Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Biobank, Department of Pathology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.\', \'Neuro-Oncology Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.\', \'Clinical Microbiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.\', \'Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Research Authority, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.\', \'Moderna, Cambridge, Massachusetts.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamaoncol.2021.2155
?:hasPublicationType
?:journal
  • JAMA oncology
is ?:pmid of
?:pmid
?:pmid
  • 34047765
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.187
?:rankingScore_hIndex
  • 41
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34047765>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34047765>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all